Noroviruses are a major cause of waterborne and foodborne acute gastroenteritis. [1] [2] [3] [4] Outbreaks of viral gastroenteritis are common because of the highly contagious nature of noroviruses. Noroviral gastroenteritis is the cause of significant morbidity and may lead to fatal infection in children, the elderly, and immuno-compromised individuals. 5 There are currently no effective vaccines or antiviral agents for combating norovirus infection; consequently, there is an urgent need for the discovery of small molecule therapeutics for the management and treatment of norovirus infection. [6] [7] Recentlyreported small molecule norovirus inhibitors include cyclic and acyclic sulfamide derivatives, [8] [9] [10] piperazine derivatives, 11 pyranobenzopyrones, 12 nitazoxanide, 13 and other chemotypes. 14 The norovirus RNA genome encodes a polyprotein which is processed by a virusencoded 3C-like cysteine protease (3CLpro) to generate mature non-structural proteins. 15 Co-and post-translational processing of the polyprotein by norovirus 3CLpro is essential for virus replication; consequently, norovirus 3CLpro is an attractive target for the discovery of anti-norovirus small molecule therapeutics.
We have recently demonstrated that peptidyl aldehydes, 16 α-ketoamides, 17 and α-ketoheterocycles 17 potently inhibit norovirus 3CLpro in vitro, as well as norovirus in a cell-based replicon system. In an attempt to identify suitably-functionalized dipeptidyl transition state inhibitors that possess potent pharmacological activity, as well as molecular properties that are important for oral bioavailability and favorable ADMET characteristics, [18] [19] [20] [21] [22] [23] [24] we describe herein for the first time the synthesis of bisulfite adducts of transition state inhibitors and their subsequent utilization in the inhibition of norovirus 3CLpro in vitro, as well as viral replication in a cell-based replicon system (Figure 1 ). To the best of our knowledge, this is the first report on the use of bisulfite adducts of transition state inhibitors to inhibit a protease. We furthermore describe the results of preliminary structure-activity relationship studies related to the probing of the S 2 subsite 25 of norovirus 3CLpro, as well as the nature of the "cap" that projects toward the S 3 subsite and beyond.
[ Figure 1 ]
The synthesis of dipeptidyl inhibitors 6a-j, 7a-j, 9, and 10 is summarized in Scheme 1.
[Scheme 1]
Reaction of an appropriate amino acid ester hydrochloride with trichloromethyl chloroformate yielded the corresponding isocyanate which was subsequently reacted with an appropriate alcohol in the presence of triethylamine to yield carbamate derivative 2. Hydrolysis with lithium hydroxide in aqueous THF followed by coupling with a glutamine surrogate 26 yielded ester 4 which was further elaborated to yield aldehydes 6a-j via sequential reduction to the alcohol with lithium borohydride, followed by DessMartin oxidation. 27 The reaction of aldehyde 6 (R 1 = benzyl, R 2 = isobutyl) with cyclopropyl isonitrile/HOAc followed by treatment with potassium carbonate in aqueous methanol yielded alcohol 8 which was then oxidized to the corresponding α-ketoamide 9 using Dess-Martin reagent. The generated aldehyde and α-ketoamide bisulfite adducts were readily obtained by stirring aldehydes 6a-j and α-ketoamide 9 with sodium bisulfite. 28 The interaction of the generated compounds with norovirus 3CLpro was investigated in vitro as previously described. [16] [17] The activity of the compounds against norovirus was also investigated in a cell-based system [29] [30] [31] [32] [33] and the combined results are listed in Table 1 .
[ Table 1] The rationale underlying the studies described herein rested on the following considerations: (a) bisulfite adducts of amino acid-derived isocyanates are readilyaccessible, stable, water-soluble solids which function as latent isocyanates. These adducts have been shown to be highly effective, time-dependent, irreversible inhibitors of mammalian serine proteases, such as neutrophil elastase, cathepsin G, and (Figure 1 ), generating the active form of the inhibitor in the gastrointestinal tract and blood plasma. In principle, the bisulfite adducts could also function as transition state mimics 36 and, (d) the high aqueous solubility and pH-dependent equilibria between the precursor carbonyl compound and adduct were also envisaged to have a significant effect on potency and the ADMET and PK characteristics of the precursor TS inhibitors.
It was envisioned that the bisulfite adducts might be suitable candidates for fulfilling such a role.
As shown in Table 1 the dipeptidyl aldehydes exhibited low to sub-micromolar inhibitory activity toward NV 3CLpro in vitro. The enzyme shows a strong preference for an R 2 = isobutyl, which is in agreement with the known substrate specificity of the enzyme. The strong preference of NV 3CLpro for a P2 Leu is supported by substrate specificity studies using peptidyl p-nitroanilide substrates, as well as X-ray crystallographic studies. 37 The results in Table 1 suggest that replacement of the isobutyl group by a cyclohexylmethyl group at R 2 yields an inhibitor that is equipotent to 6a ( Table 1 , compounds 6a and 6d). However, in sharp contrast to compound 6a, the ED 50 of compound 6d was found to be an order of magnitude lower than that of 6a, presumably because of its better cellular permeability. The nature of the "cap" (R 1   ) which projects toward the S 3 pocket and beyond was briefly explored by replacing the benzyl group with meta-and para-fluorobenzyl, 2-phenylethyl, and 2-cyclohexylethyl.
The m-fluorobenzyl and 2-cyclohexylethyl groups were equipotent to the benzyl group, and about 2-fold better than other substitutions (Table 1 , compounds 6a, 6g, 6j versus 6f and 6j).
The activity of the bisulfite adducts of the synthesized aldehydes was investigated in a cell-based system. The potency trends observed with the precursor aldehydes were generally reflected in the corresponding bisulfite salts, with bisulfite 7d (R 2 = cyclohexylmethyl) being the most potent. In order to determine the nature of the active species, the behavior of aldehyde 6a and its corresponding bisulfite salt 7a was examined by mass spectroscopy. In separate experiments, compounds 6a and 7a were dissolved in dimethyl sulfoxide and diluted 1 to 1000 in either acetonitrile or water and examined by MS and tandem MS-MS. In acetonitrile the expected peaks for aldehyde 
33
In summary, the utilization of bisulfite adducts of transition state inhibitors of serine and cysteine proteases in the in vitro and cell-based inhibition of norovirus 3CL protease has been described for the first time. 
